Matches in Wikidata for { <http://www.wikidata.org/entity/Q52717688> ?p ?o ?g. }
- Q52717688 description "2018 nî lūn-bûn" @default.
- Q52717688 description "2018年の論文" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年学术文章" @default.
- Q52717688 description "2018年學術文章" @default.
- Q52717688 description "2018年學術文章" @default.
- Q52717688 description "2018年學術文章" @default.
- Q52717688 description "2018年學術文章" @default.
- Q52717688 description "2018年學術文章" @default.
- Q52717688 description "2018년 논문" @default.
- Q52717688 description "article científic" @default.
- Q52717688 description "article scientific" @default.
- Q52717688 description "article scientifique" @default.
- Q52717688 description "articol științific" @default.
- Q52717688 description "articolo scientifico" @default.
- Q52717688 description "artigo científico" @default.
- Q52717688 description "artigo científico" @default.
- Q52717688 description "artigo científico" @default.
- Q52717688 description "artikel ilmiah" @default.
- Q52717688 description "artikull shkencor" @default.
- Q52717688 description "artikulong pang-agham" @default.
- Q52717688 description "artykuł naukowy" @default.
- Q52717688 description "artículo científico publicado en 2018" @default.
- Q52717688 description "artículu científicu" @default.
- Q52717688 description "bilimsel makale" @default.
- Q52717688 description "bài báo khoa học" @default.
- Q52717688 description "naučni članak" @default.
- Q52717688 description "scienca artikolo" @default.
- Q52717688 description "scientific article published on 23 March 2018" @default.
- Q52717688 description "scientific article published on 23 March 2018" @default.
- Q52717688 description "scientific article published on 23 March 2018" @default.
- Q52717688 description "teaduslik artikkel" @default.
- Q52717688 description "tieteellinen artikkeli" @default.
- Q52717688 description "tudományos cikk" @default.
- Q52717688 description "vedecký článok" @default.
- Q52717688 description "vetenskaplig artikel" @default.
- Q52717688 description "videnskabelig artikel" @default.
- Q52717688 description "vitenskapelig artikkel" @default.
- Q52717688 description "vitskapeleg artikkel" @default.
- Q52717688 description "vědecký článek" @default.
- Q52717688 description "wetenschappelijk artikel" @default.
- Q52717688 description "wissenschaftlicher Artikel" @default.
- Q52717688 description "επιστημονικό άρθρο" @default.
- Q52717688 description "мақолаи илмӣ" @default.
- Q52717688 description "наукова стаття, опублікована в березні 2018" @default.
- Q52717688 description "научна статия" @default.
- Q52717688 description "научная статья" @default.
- Q52717688 description "научни чланак" @default.
- Q52717688 description "научни чланак" @default.
- Q52717688 description "מאמר מדעי" @default.
- Q52717688 description "مقالة علمية نشرت في 23 مارس 2018" @default.
- Q52717688 description "২৩ মার্চ ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q52717688 description "บทความทางวิทยาศาสตร์" @default.
- Q52717688 description "სამეცნიერო სტატია" @default.
- Q52717688 name "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 name "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 type Item @default.
- Q52717688 label "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 label "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 prefLabel "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 prefLabel "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 P1433 Q52717688-85AF6BAB-EDDD-4ADB-89F3-2480DE762D92 @default.
- Q52717688 P1476 Q52717688-126D81BF-D53E-4C8F-A78F-7EBFAB06E36A @default.
- Q52717688 P2093 Q52717688-1178AB3F-8DF3-450F-B755-3A3A452D2E69 @default.
- Q52717688 P2093 Q52717688-304DE9A5-D427-47DE-8B34-9DE2367E1777 @default.
- Q52717688 P2093 Q52717688-326F4D4D-C4F1-4956-9E2C-79AF8BA290BE @default.
- Q52717688 P2093 Q52717688-621A683F-1538-4655-948D-340A025BBBD3 @default.
- Q52717688 P2093 Q52717688-7C0E8AAB-2C74-4206-90C3-414EB0087990 @default.
- Q52717688 P2093 Q52717688-C5447024-E9E5-4684-88CB-B398AC2473A0 @default.
- Q52717688 P2093 Q52717688-CD844A69-E193-43A6-AE0D-FD47F631F606 @default.
- Q52717688 P2093 Q52717688-EE854F18-FBC2-4A2F-AE72-D57C7753896F @default.
- Q52717688 P2093 Q52717688-F66C68C2-5E41-405B-A0BB-24B733FB3B59 @default.
- Q52717688 P31 Q52717688-DE0D357B-9A1C-4A10-9007-511B5976DA12 @default.
- Q52717688 P356 Q52717688-EA6B61D4-6739-4F6B-B28C-22A7B81CA3F8 @default.
- Q52717688 P407 Q52717688-BD3C12BC-7650-4467-B26A-38F57C2DBBD8 @default.
- Q52717688 P577 Q52717688-FB497991-9710-4788-895B-26DD95270DEB @default.
- Q52717688 P698 Q52717688-589C9911-3B70-4121-BAC8-6D9F9C691F2B @default.
- Q52717688 P921 Q52717688-227A6100-C8FD-4F14-9FFD-66F14A11CB03 @default.
- Q52717688 P921 Q52717688-2A76182D-276C-4F06-8555-4CB13B14A0A5 @default.
- Q52717688 P356 J.CLLC.2018.03.016 @default.
- Q52717688 P698 29681434 @default.
- Q52717688 P1433 Q332299 @default.
- Q52717688 P1476 "A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer and Systemic Inflammation." @default.
- Q52717688 P2093 "Alex Martinez-Marti" @default.
- Q52717688 P2093 "Eric Schaefer" @default.
- Q52717688 P2093 "Gerard Kennealey" @default.
- Q52717688 P2093 "Giuseppe Giaccone" @default.
- Q52717688 P2093 "Huiling Zhen" @default.
- Q52717688 P2093 "Rachel E Sanborn" @default.
- Q52717688 P2093 "Saiama N Waqar" @default.
- Q52717688 P2093 "Santiago Ponce" @default.
- Q52717688 P2093 "Susan Erickson-Viitanen" @default.
- Q52717688 P31 Q13442814 @default.
- Q52717688 P356 "10.1016/J.CLLC.2018.03.016" @default.
- Q52717688 P407 Q1860 @default.
- Q52717688 P577 "2018-03-23T00:00:00Z" @default.